Ambulatory Esophageal pH Monitoring: New Directions

pH testing remains a commonly used evaluative tool in clinical practice. However, the original tool that included a nasally placed pH catheter was plagued with a variety of shortcomings, primarily the effect of the procedure on patients’ lifestyle and thus on reflux-provoking activities. The miniaturization of evaluative techniques in gastroenterology was the impetus for the development of the wireless pH capsule and the SmartPill. These modalities improve patients’ tolerability of the required test and provide a unique opportunity for expansion of indications and data collection. The introduction of the multichannel intraluminal impedance with a pH sensor allowed the detection of gastroesophageal reflux that is non-acidic. However, the value of the technique beyond the realm of academic gastroenterology remains to be elucidated. Recently, there was a renewal of interest in Bilitec 2000. The technique, which has never found a clear clinical role, has been recommended as an important tool in evaluating patients who failed proton pump inhibitor therapy. However, data to support its clinical value in this situation have remained scant.

[1]  P J Kahrilas,et al.  An evidence-based appraisal of reflux disease management — the Genval Workshop Report , 1998, Gut.

[2]  D. Castell,et al.  Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. , 1995, Archives of internal medicine.

[3]  I. Physiopathology.  Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring , 2005 .

[4]  J. Richter,et al.  Contribution of acid and duodenogastrooesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients , 1997, Gut.

[5]  D. Castell,et al.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. , 2001, Gastroenterology.

[6]  A. Anggiansah,et al.  The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. , 1997, Gut.

[7]  J. Tack,et al.  Gastroesophageal Reflux Disease Poorly Responsive to Single-Dose Proton Pump Inhibitors in Patients without Barrett's Esophagus: Acid Reflux, Bile Reflux, or Both? , 2004, American Journal of Gastroenterology.

[8]  J. Dent,et al.  Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux , 2004, Gut.

[9]  J. Richter,et al.  Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. , 1994, Gastroenterology.

[10]  M. Vaezi,et al.  Esophageal impedance recording: Clinical utility and limitations , 2005, Current gastroenterology reports.

[11]  J. Peters,et al.  Twenty-Four Hour Ambulatory Simultaneous Impedance and pH Monitoring: A Multicenter Report of Normal Values From 60 Healthy Volunteers , 2004, American Journal of Gastroenterology.

[12]  J. Pandolfino,et al.  Prolonged pH monitoring: Bravo capsule. , 2005, Gastrointestinal endoscopy clinics of North America.

[13]  J. Richter,et al.  Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. , 1995, Gastroenterology.

[14]  R. Clouse,et al.  Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  R. Fass,et al.  24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. , 1994, Journal of clinical gastroenterology.

[16]  E. Quigley,et al.  Clinical esophageal pH recording: a technical review for practice guideline development. , 1996, Gastroenterology.

[17]  R. Fass.  Empirical Trials in Treatment of Gastroesophageal Reflux Disease , 2000, Digestive Diseases.

[18]  H. Garewal,et al.  Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns , 2003, Alimentary pharmacology & therapeutics.

[19]  Richard E. Sampliner,et al.  Effect of Ambulatory 24-Hour Esophageal pH Monitoring on Reflux-Provoking Activities , 1999, Digestive Diseases and Sciences.

[20]  H. Dupont.  Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. , 1997, The American journal of gastroenterology.

[21]  H. Wolfsen,et al.  Successful oesophageal pH monitoring with a catheter‐free system , 2004, Alimentary pharmacology & therapeutics.

[22]  J Silny,et al.  Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. , 2001, Gastroenterology.

[23]  J. Pandolfino,et al.  Comparison of the Bravo™ Wireless and Digitrapper™ Catheter-Based pH Monitoring Systems for Measuring Esophageal Acid Exposure , 2005, The American Journal of Gastroenterology.

[24]  J. Pandolfino,et al.  Ambulatory Esophageal pH Monitoring Using a Wireless System , 2003, American Journal of Gastroenterology.

[25]  R. Fass,et al.  Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trial , 2005, Alimentary pharmacology & therapeutics.

[26]  J. Richter.  Extraesophageal presentations of gastroesophageal reflux disease: an overview. , 2000, The American journal of gastroenterology.

[27]  D. Castell,et al.  Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease , 1999, American Journal of Gastroenterology.

[28]  J. Tack,et al.  Clue to a more serious diagnosis , 2005, Gut.

[29]  W. MacNaughton,et al.  The expression and role of Fas ligand in intestinal inflammation , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.